Results 91 to 100 of about 1,867,283 (205)

Additional file 2: of Non-HDL-cholesterol to HDL-cholesterol ratio is an independent risk factor for liver function tests abnormalities in geriatric population

, 2018
Figure S2. The portion of NAFLD patients according to Non-HDL/ HDL levels tertiles. The cut of values of Non-HDL / HDL ratio were  =2.96.#P value compared with Tertile 1,#P 
Hui Liu (33624), Yi Song (105202), Tianhui An (6163568), Kun Liu (148201), Mengyuan Guo (1814593), Zhaohui Wang (144332), Yi Yang (116183)   +6 more
core   +1 more source

HDL re-examined

, 2015
To summarize the current evidence concerning the role of HDL-C and HDL-associated parameters in the risk for cardiovascular disease (CVD). Numerous population studies have shown that plasma levels of HDL-C are inversely associated with CVD risk; in ...
Hovingh, G. Kees, Hegele, Robert A., Rader, Daniel J.   +2 more
core   +1 more source

LDL and HDL subfractions, dysfunctional HDL: treatment options

, 2014
Low-density lipoproteins (LDL) are considered as important risk factors for cardiovascular diseases (CVD), while highdensity lipoproteins (HDL) are well recognized for their putative role in reverse cholesterol transport and other atheroprotective ...
Garcia-Rios, Antonio, Lopez-Miranda, Jose, Hoogeveen, Ron C, Nikolic, Dragana, Perez-Martinez, Pablo, Rizzo, Manfredi   +5 more
core   +1 more source

ApoA-I mutations, L202P and K131del, in HDL from heterozygotes with low HDL-C

, 2014
PURPOSE: Mutations in apolipoprotein A-I (apoA-I) may affect plasma high-density lipoprotein (HDL) cholesterol levels and the risk for cardiovascular disease but little is known about the presence and effects of circulating apoA-I variants.
Kees Hovingh, Bochem, Andrea E., Mats Lindahl, Karlsson, Helen, Holleboom, Adriaan G., Bochem, Andrea E,, Adriaan G. Holleboom, Ljunggren, Stefan,, Lindahl, Mats,, Johannes H. M. Levels, Turkina, Maria V, Holleboom, Adriaan G, Hovingh, Kees,, Kuivenhoven, Jan Albert, Stefan Ljunggren, Andrea E. Bochem, Holleboom, Adriaan G,, Jan Albert Kuivenhoven, Sundberg, Sofie, Bochem, Andrea E, Lindahl, Mats, Ljunggren, Stefan, Levels, Johannes H M, Turkina, Maria V., Levels, Johannes H M,, Maria V. Turkina, Helen Karlsson, Sofie Sundberg, Sundberg, Sofie,, Karlsson, Helen,, Levels, Johannes H. M., Turkina, Maria V,, Kuivenhoven, Jan Albert,, Hovingh, Kees   +33 more
core   +1 more source

HDL - a difficult friend

, 2008
High-density lipoprotein (HDL) is an attractive target for antiatherogenic drug therapy because of the inverse association between HDL cholesterol and cardiovascular risk as well as many potentially antiatherogenic functions.
von Eckardstein, A
core   +1 more source

Correlations between HDL-C and HDL-P (panel A), and HDL-C and HDL size (panel B) in a virtual population of 2000 subjects.

, 2014
Correlations between HDL-C and HDL-P (panel A), and HDL-C and HDL size (panel B) in a virtual population of 2000 subjects.
James Lu (534847), M. Nazeem Nanjee (534848), Katrin Hübner (88740), Eliot A. Brinton (434267), Norman A. Mazer (534849)   +4 more
core   +1 more source

HDL molecular patholgy [PDF]

, 2000
Aunque existe una considerable evidencia epidemiológica sobre el carácter ateroprotector de las HDL, se conocen muy pocas alteraciones genéticas que expliquen los bajos niveles plasmáticos de las HDL que suponen riesgo aterosclerótico.
Sánchez De Medina López-Huertas, Fermín
core  

HDL-cholesterol or HDL-phospholipids?

Clinical Chemistry, 1981
P, Telesforo, L, Salino, A, D'Errico
openaire   +2 more sources

Association of Triglyceride-to-HDL Cholesterol Ratio with Osteoarthritis: Multicenter Evidence and Application of an Interactive Risk Visualization Tool. [PDF]

J Inflamm Res
Chen J, Hong W, Tian X, Wang W, Sun Y.
europepmc   +1 more source

HDL cholesterol/HDL particle ratio: a new measure of HDL function?

Journal of the American College of Cardiology, 2015
openaire   +3 more sources